Biotech

All Articles

Acepodia, Pfizer click together for chemistry-based tissue treatment

.Call it a scenario of excellent chemistry: Acepodia, a biotech based upon Nobel Prize-winning scien...

Praxis epilepsy medicine minimizes seizures in period 2 trial

.Practice Preciseness Medicines has racked up another midphase gain in epilepsy this year, along wit...

Three directors surrender as Dyne blog posts mixed records for DMD prospect

.After getting away a scientific hold several years back, Dyne Rehab has actually shown brand new pe...

Arrowhead fires off phase 3 records in unusual metabolic condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its give in front of a potential showdown with Ion...

Pfizer, Valneva reveal lyme condition try helpful for 2nd enhancer

.Pfizer as well as Valneva may possess about two even more years to hang around just before they cre...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's dive into a discussion along with Ayla Ellison, Ferocious Biotech Editor-in-Chief and Michell...

New data demonstrate how Bayer's asundexian failed to stop strokes

.Bayer suspended the stage 3 trial for its factor XIa inhibitor asundexian late in 2015 after the me...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its own numerous sclerosis (MS) med tolebrutinib to the F...

Galapagos' stockpile as fund reveals intent to shape its advancement

.Galapagos is happening under extra pressure coming from clients. Having created a 9.9% concern in G...

Cell- focused Sana gathers very first CSO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable leadership hirings, firings and re...